Anti-TPTE/ CT44/ PTEN2 monoclonal antibody

Anti-TPTE/ CT44/ PTEN2 antibody for FACS & in-vivo assay

Target products collectionGo to TPTE/TPTE products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1863-Ab-1/ GM-Tg-hg-MP1863-Ab-2Anti-Human TPTE monoclonal antibodyHuman
GM-Tg-rg-MP1863-Ab-1/ GM-Tg-rg-MP1863-Ab-2Anti-Rat TPTE monoclonal antibodyRat
GM-Tg-mg-MP1863-Ab-1/ GM-Tg-mg-MP1863-Ab-2Anti-Mouse TPTE monoclonal antibodyMouse
GM-Tg-cynog-MP1863-Ab-1/ GM-Tg-cynog-MP1863-Ab-2Anti-Cynomolgus/ Rhesus macaque TPTE monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1863-Ab-1/ GM-Tg-felg-MP1863-Ab-2Anti-Feline TPTE monoclonal antibodyFeline
GM-Tg-cang-MP1863-Ab-1/ GM-Tg-cang-MP1863-Ab-2Anti-Canine TPTE monoclonal antibodyCanine
GM-Tg-bovg-MP1863-Ab-1/ GM-Tg-bovg-MP1863-Ab-2Anti-Bovine TPTE monoclonal antibodyBovine
GM-Tg-equg-MP1863-Ab-1/ GM-Tg-equg-MP1863-Ab-2Anti-Equine TPTE monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1863-Ab-1/ GM-Tg-hg-MP1863-Ab-2; GM-Tg-rg-MP1863-Ab-1/ GM-Tg-rg-MP1863-Ab-2;
GM-Tg-mg-MP1863-Ab-1/ GM-Tg-mg-MP1863-Ab-2; GM-Tg-cynog-MP1863-Ab-1/ GM-Tg-cynog-MP1863-Ab-2;
GM-Tg-felg-MP1863-Ab-1/ GM-Tg-felg-MP1863-Ab-2; GM-Tg-cang-MP1863-Ab-1/ GM-Tg-cang-MP1863-Ab-2;
GM-Tg-bovg-MP1863-Ab-1/ GM-Tg-bovg-MP1863-Ab-2; GM-Tg-equg-MP1863-Ab-1/ GM-Tg-equg-MP1863-Ab-2
Products NameAnti-TPTE monoclonal antibody
Formatmab
Target NameTPTE
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TPTE benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TPTE/ CT44/ PTEN2 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1863
    Target NameTPTE
    Gene ID7179
    Gene Symbol and SynonymsCT44,PTEN2,TPTE,TPTE1
    Uniprot AccessionP56180
    Uniprot Entry NameTPTE_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000274391
    Target ClassificationN/A

    The target: TPTE, gene name: TPTE, also named as CT44, PTEN2. This gene encodes a PTEN-related tyrosine phosphatase which may play a role in the signal transduction pathways of the endocrine or spermatogenic function of the testis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.